Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
2m agoQuarterly Activities Report - March 2026
31m agoAppendix 4C and Quarterly Activities Report - March 2026
57m agoDiagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
57m agoING completes share buyback and announces new programme of up to €1.0 billion
58m agoargenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
Valneva Se logo

Valneva Se

About

Valneva Se — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 26 2026
Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC
Mar 23 2026
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
Mar 18 2026
Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program
Mar 18 2026
Valneva Reports Full Year 2025 Audited Consolidated Financial Results
Mar 9 2026
Valneva to Report Full Year 2025 Consolidated Financial Results on March 18, 2026

Community Chat

Ask AI

6ix6ix